Skip to content

Nadia Solowij

13 papers in the library · 673 citations · publishing 1992-2026

Papers

Sort Most recent Most cited

How does cognition change over time in young people who use cannabis recreationally? A narrative review of the longitudinal literature to date

Psychopharmacology May 11, 2026 Gabrielle Abbott, Lisa-Marie Greenwood, Jessica G. Bartschi et al.

Abstract Introduction The regular consumption of cannabis has been associated with changes in cognition. However it is unclear how cognitive performance changes over time with continued cannabis use and whether cognitive alterations predate the onset of cannabis use. We conducted a narrative review of longitudinal observational naturalistic studies of cognition in people who use cannabis....

Daily Cannabidiol Administration for 10 Weeks Modulates Hippocampal and Amygdalar Resting-State Functional Connectivity in Cannabis Users: A Functional Magnetic Resonance Imaging Open-Label Clinical Trial

Cannabis and Cannabinoid Research July 26, 2023 Valentina Lorenzetti, Eugene McTavish, Samantha J Broyd et al.

Introduction: Cannabis use is associated with brain functional changes in regions implicated in prominent neuroscientific theories of addiction. Emerging evidence suggests that cannabidiol (CBD) is neuroprotective and may reverse structural brain changes associated with prolonged heavy cannabis use. In this study, we examine how an ∼10-week exposure of CBD in cannabis users affected...

Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis

The World Journal of Biological Psychiatry March 22, 2022 Deepak C. D’Souza, Marta DiForti, Suhas Ganesh et al.

Abstract Objectives The liberalisation of cannabis laws, the increasing availability and potency of cannabis has renewed concern about the risk of psychosis with cannabis. Methods The objective of the WFSBP task force was to review the literature about this relationship. Results Converging lines of evidence suggest that exposure to cannabis increases the risk for psychoses ranging from...

Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial.

Cannabis and Cannabinoid Research March 1, 2018 Nadia Solowij, Samantha J Broyd, Camilla Beale et al.

Introduction: Chronic cannabis use has been associated with impaired cognition and elevated psychological symptoms, particularly psychotic-like experiences. While Δ9-tetrahydrocannabinol (THC) is thought to be primarily responsible for these deleterious effects, cannabidiol (CBD) is purported to have antipsychotic properties and to ameliorate cognitive, symptomatic, and brain harms in cannabis...

Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review.

Biological Psychiatry April 1, 2016 Samantha J Broyd, Hendrika H Van Hell, Camilla Beale et al.

Cannabis use has been associated with impaired cognition during acute intoxication as well as in the unintoxicated state in long-term users. However, the evidence has been mixed and contested, and no systematic reviews of the literature on neuropsychological task-based measures of cognition have been conducted in an attempt to synthesize the findings. We systematically review the empirical...

Mismatch Negativity and P50 Sensory Gating in Abstinent Former Cannabis Users

Journal of Neural Transplantation and Plasticity February 25, 2016 Samantha J Broyd, L. Greenwood, Hendrika H Van Hell et al.

Prolonged heavy exposure to cannabis is associated with impaired cognition and brain functional and structural alterations. We recently reported attenuated mismatch negativity (MMN) and altered P50 sensory gating in chronic cannabis users. This study investigated the extent of brain functional recovery (indexed by MMN and P50) in chronic users after cessation of use. Eighteen ex-users (median...

Hippocampal harms, protection and recovery following regular cannabis use.

Translational Psychiatry January 12, 2016 Murat Yücel, Valentina Lorenzetti, Chao Suo et al.

Shifting policies towards legalisation of cannabis for therapeutic and recreational use raise significant ethical issues for health-care providers seeking evidence-based recommendations. We investigated whether heavy cannabis use is associated with persistent harms to the hippocampus, if exposure to cannabidiol offers protection, and whether recovery occurs with abstinence. To do this, we...

The association between regular cannabis exposure and alterations of human brain morphology: an updated review of the literature.

Current Pharmaceutical Design 2014 Valentina Lorenzetti, Nadia Solowij, Alex Fornito et al.

Cannabis is the most widely used illicit drug worldwide, though it is unclear whether its regular use is associated with persistent alterations in brain morphology. This review examines evidence from human structural neuroimaging investigations of regular cannabis users and focuses on achieving three main objectives. These include examining whether the literature to date provides evidence that...

Chronic cannabis users show altered neurophysiological functioning on Stroop task conflict resolution.

Psychopharmacology December 2010 Robert A Battisti, Steven Roodenrys, Stuart J Johnstone et al.

Chronic cannabis use has been related to deficits in cognition (particularly memory) and the normal functioning of brain structures sensitive to cannabinoids. There is increasing evidence that conflict monitoring and resolution processes (i.e. the ability to detect and respond to change) may be affected. This study examined the ability to inhibit an automatic reading response in order to...

Structural MRI findings in long-term cannabis users: what do we know?

Substance Use & Misuse September 2010 Valentina Lorenzetti, Dan I Lubman, Sarah Whittle et al.

In animal studies, tetrahydrocannabinol (THC) has been found to affect brain morphology, particularly within areas rich in cannabinoid receptors (e.g., hippocampus, cerebral cortex). While cannabis remains the most widely used illicit drug worldwide, there has been limited work investigating its effects on human brain tissue. In this paper, we conducted a systematic review of existing...

The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample

Schizophrenia Bulletin July 25, 2010 Murat Yücel, Emre Bora, Dan Ian Lubman et al. 256 citations

Cannabis use is highly prevalent among people with schizophrenia, and coupled with impaired cognition, is thought to heighten the risk of illness onset. However, while heavy cannabis use has been associated with cognitive deficits in long-term users, studies among patients with schizophrenia have been contradictory. This article consists of 2 studies. In Study I, a meta-analysis of 10 studies...

Chronic use of cannabis and poor neural efficiency in verbal memory ability.

Psychopharmacology May 2010 Robert A Battisti, Steven Roodenrys, Stuart J Johnstone et al.

The endogenous cannabinoid system is sensitive to the introduction of exogenous cannabinoids such as delta-9-tetrahydrocannabinol, which are known to impact upon memory functioning. We sought to examine the impact of chronic cannabis use upon memory-related brain function via examination of the subsequent memory effect (SME) of the event-related potential (ERP). The SME is predictive of recall...

Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug

British Journal of Addiction August 1, 1992 Nadia Solowij, Wayne Hall, Nicole Lee 417 citations

Abstract ‘Ecstasy’ (3,4‐methylenedioxymethampketamine or MDMA) is a recreational drug that is gaining popularity world wide. There is a paucity of research regarding the ways in which Ecstasy is used and the nature of its effects. A ‘snowball’ peer network technique was used to recruit 100 users who completed anonymous questionnaires. The research revealed that Ecstasy is primarily used by...

DOI: 10.1111/j.1360-0443.1992.tb02003.x (opens in new tab) Ecstasy MDMA Recreational use Recreational drug use +2